Category list : Anti-infective agents
Sort by: Newest first Oldest first A-Z Z-A
-
GPs who prescribe fewer antibiotics get lower patient satisfaction scores Subscription
GPs who refuse to prescribe antibiotics to patients are likely to receive poorer patient satisfaction scores, study suggests.
-
Fluoroquinolone use associated with aortic aneurysm Subscription
Study finds patients who have recently taken fluoroquinolones were twice as likely to experience aortic aneurysm.
-
Alcoholism drug could help eliminate dormant HIV Subscription
Disulfiram treatment can reactivate latent HIV, which could help eliminate the cells harbouring the virus, report finds.
-
People taking HIV drugs rises to almost 16 million, UNAIDs reports Subscription
The number of people receiving HIV treatment reached 15.8 million in June 2015, an increase of 2.2 million on the previous year, says a new report by UNAIDS.
-
A history of HIV survival in the UK Subscription
Treatment for HIV has radically improved since the beginning of the epidemic in 1981. HIV-infected people in the UK are now surviving for decades, rather than months or years.
-
Working to support antimicrobial surveillance and stewardship practices Subscription
Two months since his election to chair of the Royal Pharmaceutical Society Antimicrobial Expert Advisory Group, Harpal Dhillon talks to Julia Robinson about the role of the group and how pharmacists can best use their skills to tackle inappropriate antibiotic use.
-
Antibiotic prescriptions in England fall after 2012 peak Subscription
Antibiotic prescribing by GPs in England has fallen by 5.6% since 2012 following national efforts to slow the spread of bacterial resistance.
-
Fewer antibiotics prescribed when doctors share decision with patients Subscription
Fewer antibiotic prescriptions are issued for acute respiratory infections when doctors share decision making with patients, according to a review published by the Cochrane Library on 12 November 2015.
-
Learn how to manage infectious disease Subscription
‘Infectious disease pharmacotherapy self assessment’, by Lea S Eiland and Diane B Ginsburg.
-
Reyataz boosted regimen Subscription
Ordinarily, treatment of HIV-1 with Reyataz (atazanavir; Bristol Myers Squibb) is boosted by co-administration with ritonavir. However, the summary of product characteristics has been updated to reflect that, under certain circumstances, ritonavir does not need to be co-administered, for example in patients with hepatic impairment.
Show 10 per page20 per page50 per page
